Feature

Research Reports

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival

10/21/2020

Aimee Ginsburg , PharmD, BCPS;

J. Russell Hoverman , MD, PhD;

Angela Hsieh , PharmD, BCOP;

Kartik Konduri , MD;

Leslie T. Busby , MD;

Lalan Wilfong , MD;

John M. Burke , MD;

Marcus A. Neubauer , MD;

Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...

...

10/21/2020

Journal of Clinical Pathways

Perspectives

Supporting Optimal, Value-Based, and Sustainable Cancer Care Delivery

10/21/2020

Anita Pudusseri , DO;

Paul J. Hesketh , MD;

Sylvia Richey , MD;

Lee Schwartzberg , MD, FACP;

Rebecca Stein ;

Wui-Jin Koh , MD;

Tyler Haydell ;

Corrine Zarwan , MD;

Barbara McAneny , MD;

Alison Fugaro , PA;

Edward Arrowsmith , MD;

Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...

...

10/21/2020

Journal of Clinical Pathways

From the Field

Developing Pathway to Cure: A Multimodal Clinical Pathway Platform to Support Timely and Appropriate Care of Women Under 50 Diagnosed With Breast Cancer

09/18/2020

Robin M. Lally , PhD, MS, RN, AOCN, FAAN;

Roksana Zak , PhD;

Allison F. Coates , BS, BSN, RN;

Elizabeth Reed , MD;

Ryan Ramaekers , MD;

Abstract: Pathway to Cure is a multimodal eHealth platform for oncology care providers and patients developed by a multidisciplinary team at the University of Nebraska Medical Center’s Fred & Pamela Buffett...

...

09/18/2020

Journal of Clinical Pathways

Perspectives

Primary Care Increasingly on the Front Lines of Clinical Genetics: Standard Practice and Data Concerns

09/18/2020

Joel Diamond , MD, FAAFP;

Abstract: Many health care leaders find themselves in an unexpected situation as market awareness around precision medicine grows: primary care providers increasingly have become the front line for genetic and...

...

09/18/2020

Journal of Clinical Pathways

Research Reports

Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib

08/19/2020

Gary H. Lyman , MD, MPH, FASCO, FRCP, FACP;

David R. Doody , MS;

Shasank Chennupati , PharmD, MPH;

Eric J. Chow , MD, MPH;

Lena E. Winestone , MD, MSHP;

Henry J. Henk , PhD;

Pamela Morin , MBA;

Jennifer J. Wilkes , MD, MSCE;

Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...

...

08/19/2020

Journal of Clinical Pathways

From the Field

Care Coordination Between Prescribers and the Specialty Pharmacy for Multiple Myeloma: Qualitative Insights Into Designing a Quality Improvement Program for Multisite Community Oncology Practices

08/19/2020

Jeffrey F. Patton , MD;

David Blaisdell , BA;

Jonathan K. Kish , PhD, MPH;

Natalie Dickson , MD;

JaLyna Laney , RN, OCN;

Jesus G. Berdeja , MD;

Stacey W. McCullough , PharmD;

Annette Powers , PharmD, MBA;

Ronda Copher , PhD;

Tom Valuck , MD, JD;

Abstract: It is widely recognized that the quality of medical care received in the United States is suboptimal, and poor-quality care may contribute to disparities in cancer incidence and mortality. While...

...

08/19/2020

Journal of Clinical Pathways

From the Field

Insights Gained From a Pilot Study Investigating Early Survivorship Care Interventions

06/17/2020

Deborah Christensen , MSN, APRN;

Cheryl Bellomo , MSN, RN, OCN;

Bonita S. Agee , PhD;

Abstract: Intermountain Healthcare, a Utah-based, not-for-profit organization, co-sponsored a pilot study to evaluate potential benefits of early survivorship care by offering a treatment summary and survivorship...

...

06/17/2020

Journal of Clinical Pathways

Perspectives

COVID-19 Pandemic Vindicates the ISPOR Value Flower

06/17/2020

Kathy Lang , PhD;

Jason Shafrin , PhD;

Ross Maclean , MD;

Abstract: What is the right price for a new treatment for COVID-19? One common approach—which is frequently used worldwide and in the United States by the Institute of Clinical and Economic Review—measures treatment...

...

06/17/2020

Journal of Clinical Pathways

Research Reports

The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis

05/19/2020

Abdalla Aly , PhD;

Yunes Doleh , MPH, PharmD;

Marc Botteman , MSc;

Courtney Johnson , MPH;

Viktor Chirikov , MS, PhD;

Arif Hussain , MD;

Rahul Shenolikar , MS, PhD;

Abstract: Urothelial carcinoma (UC) is generally diagnosed early and may incur significant lifetime costs. This study estimated, from the payer’s perspective, the lifetime costs among patients diagnosed with UC...

...

05/19/2020

Journal of Clinical Pathways

From the Field

Enhancing the Electronic Health Record to Improve the Quality of Breast Cancer Care in Eastern North Carolina

05/19/2020

Andrew Weil , MD;

Jan H. Wong , MD;

Lauren E. Geisel , MD;

Mahvish Muzaffar , MD;

Phyllis DeAntonio , RN;

Nasreen A. Vohra , MD;

Helen M. Johnson , MD;

Abstract: Eastern North Carolina (ENC) is home to a rural population that suffers from disparities in breast cancer outcomes. It has been demonstrated that evidence-based clinical pathways can improve quality of...

...

05/19/2020

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products